Though the rise in methamphetamine harms observed over the last 10 years is not as great as those associated with opioids, this increase should not be ignored. The federal government could capitalize on those investments already made to address the opioid crisis by using them to address the increase in the use of methamphetamine.
These measures include continued prioritizing and investing in better data and knowledge sharing on drug use and harms in Canada through continued development of the Canadian drugs observatory, which the committee heard about in the previous session, and support for the Canadian Community Epidemiology Network on Drug Use; investing upstream to reduce inequities in the social determinants of health and increase resiliency and self-efficacy in youth; reducing stigma by promoting understanding of substance use as a health issue, increasing the availability and accessibility of an evidence-informed, client-centred continuum of services and supports; supporting interventions to reduce harms specific to methamphetamine use, such as outreach education, needle exchange, pipes that reduce burns and cuts and other methods to reduce the spread of communicable disease; and finally, investing in low threshold housing.
CCSA will continue to coordinate collective efforts, connect partners, gather and share evidence, identify emerging issues and address stakeholder needs according to our mandate.
On behalf of Dr. Fandrey and the CCSA, I would like to thank the committee for the opportunity to speak today on this important issue. We will be pleased to respond to your questions.